Journal of Surgical Research
Volume 142, Issue 1 , Pages 59-65 , September 2007

Hemofiltration and Immune Response in Severe Sepsis

Received 8 May 2006

References 

  1. Angus DC, Wax RS. Epidemiology of sepsis: An update. Crit Care Med. 2001;29:S109
  2. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546
  3. Deitch EA. Animal models of sepsis and shock: A review and lessons learned. Shock. 1998;9:1
  4. O’Reilly M, Newcomb DE, Remick D. Endotoxin, sepsis, and the primrose path. Shock. 1999;12:411
  5. Gea-Banacloche JC, Opal SM, Jorgensen J, et al. Sepsis associated with immunosuppressive medications: An evidence-based review. Crit Care Med. 2004;32:S578
  6. Weigand MA, Horner C, Bardenheuer HJ, et al. The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol. 2004;18:455
  7. Heidecke CD, Hensler T, Weighardt H, et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg. 1999;178:288
  8. Doecke W-D, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment. Nat Med. 1997;3:678
  9. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001;163:316
  10. Pugin J, Ricou B, Steinberg KP, et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 1996;153:1850
  11. Ertel W, Kremer JP, Kenney J, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995;85:1341
  12. Rodby RA. Hemofiltration for SIRS: Bloodletting, twentieth century style?. Crit Care Med. 1998;26:1940
  13. Silvester W. Mediator removal with CRRT: Complement and cytokines. Am J Kidney Dis. 1997;30:S38
  14. Cole L, Bellomo R, Hart G, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med. 2002;30:100
  15. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858
  16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644
  17. Weigand MA, Schmidt H, Zhao Q, et al. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg. 2000;90:206
  18. Song M, Kellum JA. Interleukin-6. Crit Care Med. 2005;33:S463
  19. Scumpia PO, Moldawer LL. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med. 2005;33:S468
  20. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138
  21. Park WY, Goodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164:1896
  22. Rivera-Chavez FA, Wheeler H, Lindberg G, et al. Regional and systemic cytokine responses to acute inflammation of the vermiform appendix. Ann Surg. 2003;237:408
  23. Tschaikowsky K, Hedwig-Geissing M, Schiele A, et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med. 2002;30:1015

1 This work was performed at the University of Heidelberg.

PII: S0022-4804(06)00494-X

doi: 10.1016/j.jss.2006.09.019

Journal of Surgical Research
Volume 142, Issue 1 , Pages 59-65 , September 2007

Article Tools

* Image Usage & Resolution